BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24258815)

  • 1. A novel and essential role for FcγRIIa in cancer cell-induced platelet activation.
    Mitrugno A; Williams D; Kerrigan SW; Moran N
    Blood; 2014 Jan; 123(2):249-60. PubMed ID: 24258815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii.
    Keane C; Petersen H; Reynolds K; Newman DK; Cox D; Jenkinson HF; Newman PJ; Kerrigan SW
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2408-15. PubMed ID: 21071690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet Activation and Thrombus Formation over IgG Immune Complexes Requires Integrin αIIbβ3 and Lyn Kinase.
    Zhi H; Dai J; Liu J; Zhu J; Newman DK; Gao C; Newman PJ
    PLoS One; 2015; 10(8):e0135738. PubMed ID: 26291522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.
    Boylan B; Gao C; Rathore V; Gill JC; Newman DK; Newman PJ
    Blood; 2008 Oct; 112(7):2780-6. PubMed ID: 18641368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3.
    Watson CN; Kerrigan SW; Cox D; Henderson IR; Watson SP; Arman M
    Platelets; 2016 Sep; 27(6):535-40. PubMed ID: 27025455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for p38 MAP kinase in platelet activation by von Willebrand factor.
    Canobbio I; Reineri S; Sinigaglia F; Balduini C; Torti M
    Thromb Haemost; 2004 Jan; 91(1):102-10. PubMed ID: 14691575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3.
    Pampolina C; McNicol A
    Thromb Haemost; 2005 May; 93(5):932-9. PubMed ID: 15886812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.
    Navarro-Núñez L; Pollitt AY; Lowe K; Latif A; Nash GB; Watson SP
    Thromb Haemost; 2015 May; 113(5):1109-20. PubMed ID: 25694214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF; Chang CH; Ho PL; Chung CH
    Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.
    Zhi H; Rauova L; Hayes V; Gao C; Boylan B; Newman DK; McKenzie SE; Cooley BC; Poncz M; Newman PJ
    Blood; 2013 Mar; 121(10):1858-67. PubMed ID: 23264598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FcgammaRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation.
    Gratacap MP; Hérault JP; Viala C; Ragab A; Savi P; Herbert JM; Chap H; Plantavid M; Payrastre B
    Blood; 2000 Nov; 96(10):3439-46. PubMed ID: 11071639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.
    Pearce AC; Wonerow P; Marshall SJ; Frampton J; Gartner TK; Watson SP
    Biochem J; 2004 Feb; 378(Pt 1):193-9. PubMed ID: 14558887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis.
    Arman M; Krauel K
    J Thromb Haemost; 2015 Jun; 13(6):893-908. PubMed ID: 25900780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand.
    Martin EM; Clark JC; Montague SJ; Morán LA; Di Y; Bull LJ; Whittle L; Raka F; Buka RJ; Zafar I; Kardeby C; Slater A; Watson SP
    J Thromb Haemost; 2024 Jan; 22(1):271-285. PubMed ID: 37813196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor.
    Fitzgerald JR; Loughman A; Keane F; Brennan M; Knobel M; Higgins J; Visai L; Speziale P; Cox D; Foster TJ
    Mol Microbiol; 2006 Jan; 59(1):212-30. PubMed ID: 16359330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new role for FcgammaRIIA in the potentiation of human platelet activation induced by weak stimulation.
    Canobbio I; Stefanini L; Guidetti GF; Balduini C; Torti M
    Cell Signal; 2006 Jun; 18(6):861-70. PubMed ID: 16169188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine dephosphorylation, but not phosphorylation, of p130Cas is dependent on integrin alpha IIb beta 3-mediated aggregation in platelets: implication of p130Cas involvement in pathways unrelated to cytoskeletal reorganization.
    Ohmori T; Yatomi Y; Inoue K; Satoh K; Ozaki Y
    Biochemistry; 2000 May; 39(19):5797-807. PubMed ID: 10801330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice.
    Zhou Y; Abraham S; Renna S; Edelstein LC; Dangelmaier CA; Tsygankov AY; Kunapuli SP; Bray PF; McKenzie SE
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2315-2323. PubMed ID: 27765766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation mediated through membrane glycoproteins: involvement of tyrosine kinases.
    Ozaki Y; Qi R; Satoh K; Asazuma N; Yatomi Y
    Semin Thromb Hemost; 2000; 26(1):47-51. PubMed ID: 10805282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibalpha is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway.
    Marshall SJ; Asazuma N; Best D; Wonerow P; Salmon G; Andrews RK; Watson SP
    Biochem J; 2002 Jan; 361(Pt 2):297-305. PubMed ID: 11772401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.